[Urodynamic studies on detrusor hyperreflexia. II. Pharmacological and physiological suppression of the detrusor hyperreflexia (author's transl)].
D000368:Aged; D001003:Anal Canal / Q000502:physiology; D000775:Anesthesia, Spinal; D002086:Butylscopolammonium Bromide / Q000494:pharmacology; D004177:Dipyrone / Q000494:pharmacology; D004338:Drug Combinations / Q000494:pharmacology; D005260:Female; D005422:Flavoxate / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000494:pharmacology; D010812:Physical Stimulation; D012021:Reflex, Abnormal / Q000503:physiopathology*; D001743:Urinary Bladder / Q000187:drug effects / Q000503:physiopathology*; D001745:Urinary Bladder Diseases / Q000503:physiopathology*; D014563:Urodynamics / Q000187:drug effects
D004338:Drug Combinations; D010276:Parasympatholytics; C020432:dypyrone, hyoscine butylbromide drug combination; D002086:Butylscopolammonium Bromide; D005422:Flavoxate; D004177:Dipyrone